Cipla | CIPLA - Current Assets

Stock Price
1,317.80
Daily Change
-23.30 -1.74%
Monthly
0.37%
Yearly
-10.76%
Q1 Forecast
1,315.62

Cipla reported INR249.18B in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Arca Biopharma USD 355.16M 23.15M Sep/2025
aTyr Pharma USD 93.01M 5.52M Sep/2025
Bio Path USD 680K 1.44M Jun/2025
Brainstorm Cell Therapeutics USD 508K 1.01M Sep/2025
Capricor Therapeutics USD 100.95M 23.18M Sep/2025
Cara Therapeutics USD 43.13M 4.18M Jun/2025
Cipla INR 249.18B 16.3B Sep/2025
Dr.Reddys Laboratories INR 297.55B 18.03B Dec/2025
Esperion Therapeutics USD 360.46M 17.87M Sep/2025
Immunic USD 39.27M 20.57M Sep/2025
Infinity Pharmaceuticals USD 19.91M 8.46M Jun/2023
Minerva Neurosciences USD 13.02M 2.53M Sep/2025
Nektar Therapeutics USD 281.36M 94.79M Sep/2025
Sangamo BioSciences USD 49.89M 12.3M Jun/2025
Sun Pharmaceuticals INR 601.36B 75.42B Sep/2025
TherapeuticsMD USD 11.82M 303K Jun/2024
UPL INR 412.98B 16.37B Sep/2025